SCHEMBL6370588

SCHEMBL6370588

CC(C)(C)c1cc(Cl)cn2ccnc12

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.42
TNKS O95271 2/20 0.38
HTR3A P46098 1/20 0.38
NUDT1 P36639 1/20 0.34
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
LMNA P02545 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
PKM P14618 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
ALOX12 P18054 1/20 0.32
HSD17B10 Q99714 1/20 0.32
AURKA O14965 1/20 0.31
KCNH2 Q12809 1/20 0.31
HPGD P15428 1/20 0.31
HTT P42858 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24857525 0.80 L3MBTL1 (0.47) L3MBTL1TNKSNUDT1KDM4EALDH1A1
SCHEMBL24857448 0.79 L3MBTL1 (0.42) L3MBTL1TNKSNUDT1KDM4EALDH1A1
SCHEMBL16705075 0.78 L3MBTL1 (0.62) L3MBTL1TNKSHTR3ANUDT1KDM4E
SCHEMBL22490650 0.77 L3MBTL1 (0.43) L3MBTL1TNKSHTR3ANUDT1AURKA
SCHEMBL14006669 0.76 NUDT1 (0.47) L3MBTL1HTR3ANUDT1ALDH1A1GAA
SCHEMBL25974824 0.74 L3MBTL1 (0.41) L3MBTL1TNKSHTR3ANUDT1AURKA
SCHEMBL1983144 0.74 L3MBTL1 (0.49) L3MBTL1TNKSHTR3ANUDT1ALDH1A1
SCHEMBL24857368 0.74 L3MBTL1 (0.41) L3MBTL1TNKSHTR3ANUDT1AURKA
SCHEMBL15828609 0.74 TNKS (0.43) L3MBTL1TNKSNUDT1KDM4EALDH1A1
SCHEMBL10135729 0.74 L3MBTL1 (0.41) L3MBTL1TNKSHTR3ANUDT1AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002414-A1 AZAHETEROARYL COMPOUND AND APPLICATION THEREOF SHANGHAI BLUERAY BIOPHARMA CO., LTD. (CN) 2023-01-05 US disclosed
US-9029377-B2 Platelet-activating factor receptor antagonists MERCK SHARP & DOHME CORP. (US) 2015-05-12 US disclosed
US-20120108595-A1 PLATELET-ACTIVATING FACTOR RECEPTOR ANTAGONISTS MERCK SHARP & DOHME LLC 2012-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108595-A1 PLATELET-ACTIVATING FACTOR RECEPTOR ANTAGONISTS PTAFR, PAFAH1B2, PAFAH1B3 L3MBTL1 4449/4885TNKS 457/4885HTR3A 1463/4885
US-20230002414-A1 AZAHETEROARYL COMPOUND AND APPLICATION THEREOF EZH2, EED, SUZ12 L3MBTL1 3524/4885TNKS 2280/4885HTR3A 3886/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.